Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus

Journal of Clinical Lipidology

Volumn 5, Issue 6, 2011, Pages 467-473

  Tan, Hong Chang ^a   Tai, E Shyong ^b   Sviridov, Dmitri ^c   Nestel, Paul J ^c   Ng, Cindy ^a   Chan, Edmund ^a   Teo, Yvonne ^a   Wai, Daniel Chun Hang ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

ApoB depleted plasma; Diabetic dyslipidemia; HDL particles; Nuclear magnetic resonance; Reverse cholesterol transport

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; CHOLESTEROL; EZETIMIBE; FIBRIC ACID DERIVATIVE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TRITIUM;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; DYSLIPIDEMIA; FEMALE; HUMAN; ISOTOPE LABELING; MACROPHAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RADIOACTIVITY;

ADULT; AGED; ANTHROPOMETRY; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CHOLESTEROL; CULTURE MEDIA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LINEAR MODELS; LIPOPROTEINS, HDL; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 81855204973     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.06.016     Document Type: Article

References (36)

1. A. Kontush, and M.J. Chapman Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis Pharmacol Rev 58 2006 342 374 (Pubitemid 44394906)
2. W.P. Castelli, R.J. Garrison, P.W. Wilson, R.D. Abbott, S. Kalousdian, and W.B. Kannel Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study JAMA 256 1986 2835 2838 (Pubitemid 17178361)
3. A.V. Khera, M. Cuchel, and M. de la Llera-Moya Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N Engl J Med 364 2011 127 135
4. S.M. Haffner, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234 (Pubitemid 28350165)
5. W.T. Garvey, S. Kwon, and D. Zheng Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance Diabetes 52 2003 453 462 (Pubitemid 36173203)
6. S. Mora, J.D. Otvos, N. Rifai, R.S. Rosenson, J.E. Buring, and P.M. Ridker Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women Circulation 119 2009 931 939
7. K. El Harchaoui, B.J. Arsenault, and R. Franssen High-density lipoprotein particle size and concentration and coronary risk Ann Intern Med 150 2009 84 93
8. E. Cavallero, F. Brites, and B. Delfly Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles Arterioscler Thromb Vasc Biol 15 1995 2130 2135 (Pubitemid 26001413)
9. J.D. Otvos, D. Collins, and D.S. Freedman Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial Circulation 113 2006 1556 1563 (Pubitemid 43739414)
10. M.R. Taskinen, T. Kuusi, E. Helve, E.A. Nikkilä, and H. Yki-Järvinen Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes Arteriosclerosis 8 1988 168 177 (Pubitemid 18090925)
11. S. Mora, M. Szklo, and J.D. Otvos LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA) Atherosclerosis 192 2007 211 217 (Pubitemid 46602300)
12. E.J. Jeyarajah, W.C. Cromwell, and J.D. Otvos Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy Clin Lab Med 26 2006 847 870 (Pubitemid 44716510)
13. J.A. Shaw, A. Bobik, and A. Murphy Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque Circ Res 103 2008 1084 1091
14. S. Larrede, C.M. Quinn, and W. Jessup Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent Arterioscler Thromb Vasc Biol 29 2009 1930 1936
15. R.S. Rosenson, H.B. Brewer, and M.J. Chapman HDL Measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events Clin Chem 57 2011 392 410
16. L.H. Kuller, G. Grandits, J.D. Cohen, J.D. Neaton, R. Prineas Group MRFITR Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome Atherosclerosis 195 2007 122 128 (Pubitemid 47566381)
17. E. Favari, L. Calabresi, and M.P. Adorni Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1 Biochemistry 48 2009 11067 11074
18. M. Syvänne, G. Castro, and C. Dengremont Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I: A-II particles and phospholipid transfer protein Atherosclerosis 127 1996 245 253 (Pubitemid 27045838)
19. P.B. Duell, J.F. Oram, and E.L. Bierman Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux Diabetes 40 1991 377 384
20. A. Hoang, A.J. Murphy, and M.T. Coughlan Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties Diabetologia 50 2007 1770 1779 (Pubitemid 47036662)
21. Y. Aso, T. Inukai, K. Tayama, and Y. Takemura Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes Acta Diabetol 37 2000 87 92 (Pubitemid 32009315)
22. E. Nobécourt, S. Jacqueminet, and B. Hansel Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia Diabetologia 48 2005 529 538 (Pubitemid 40487300)
23. H. Zhou, K.C.B. Tan, S.W.M. Shiu, and Y. Wong Cellular cholesterol efflux to serum is impaired in diabetic nephropathy Diabetes Metab Res Rev 24 2008 617 623
24. P. Linsel-Nitschke, H. Jansen, and Z. Aherrarhou Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography Lipids Health Dis 8 2009 14
25. W.A. van der Steeg, I. Holme, and S.M. Boekholdt High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies J Am Coll Cardiol 51 2008 634 642 (Pubitemid 351186873)
26. J.M. Lawrence, J. Reid, G.J. Taylor, C. Stirling, and J.P.D. Reckless Favorable effects of pioglitazone and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes Diabetes Care 27 2004 41 46 (Pubitemid 38196707)
27. R.S. Rosenson, J.D. Otvos, and J. Hsia Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study Diabetes Care 32 2009 1087 1091
28. K. Ikewaki, J-i. Tohyama, Y. Nakata, T. Wakikawa, T. Kido, and S. Mochizuki Fenofibrate effectively reduces remnants, and small dense LDL, and increases HDL particle number in hypertriglyceridemic men - a nuclear magnetic resonance study J Atheroscler Thromb 11 2004 278 285
29. J.T. Kuvin, D.M. Dave, and K.A. Sliney Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease Am J Cardiol 98 2006 743 745 (Pubitemid 44301006)
30. M. Yamashita, N. Tamasawa, and K. Matsuki Insulin suppresses HDL-mediated cholesterol efflux from macrophages through inhibition of neutral cholesteryl ester hydrolase and ATP-binding cassette transporter G1 expressions J Atheroscler Thromb 17 2010 1183 1189
31. K. Matsuki, N. Tamasawa, and M. Yamashita Metformin restores impaired HDL-mediated cholesterol efflux due to glycation Atherosclerosis 206 2009 434 438
32. G. Chinetti, S. Lestavel, and V. Bocher PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat Med 7 2001 53 58 (Pubitemid 32095642)
33. M. Guerin, P. Egger, and C. Soudant Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux Atherosclerosis 163 2002 287 296 (Pubitemid 34615819)
34. H. Sone, H. Shimano, and M. Shu Statins downregulate ATP-binding-cassette transporter A1 gene expression in macrophages Biochem Biophys Res Commun 316 2004 790 794 (Pubitemid 38368021)
35. S.M. Gordon, J. Deng, L.J. Lu, and W.S. Davidson Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography J Proteome Res 9 2010 5239 5249
36. D. Sviridov, A. Hoang, E. Ooi, G. Watts, P.H.R. Barrett, and P. Nestel Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin Atherosclerosis 197 2008 732 739 (Pubitemid 351417870)